The Centers for Disease Control and Prevention (CDC) published updated guidance communicating to the public that the coronavirus disease 2019 is an airborne threat, explicitly stating that transmission and subsequent infection with the novel coronavirus can occur via inhalation of very fine respiratory droplets as well as aerosolized particles.
Children attending summer camp can get within 3 feet (1 meter) of each other but should wear masks to limit the spread of Covid-19, according to fresh guidance issued by the U.S. Centers for Disease Control and Prevention.
The U.S. State Department will boost its “Do Not Travel” guidance to about 80 percent of countries worldwide, citing “unprecedented risk to travelers” from the Covid-19 pandemic.
The U.S. Food and Drug Administration issued new guidance for vaccine makers as the regulatory agency is preparing for the possibility of needing to approve Covid-19 booster shots against variants of the SARS-CoV-2 virus.
U.S. public health officials said a second Covid-19 shot could be administered as much as six weeks apart from the first one in situations where it was not possible to get a booster dose immediately.
A U.S. Centers for Disease Control and Prevention advisory panel on Dec. 12 recommended the nation’s first COVID-19 vaccine, helping clear the way for public health authorities to begin the largest vaccination campaign in U.S. history.
After months of urging the public to wear masks and facial coverings to help stop infected people from spreading Covid-19, the Centers for Disease Control and Prevention (CDC) stated in newly released guidance that masks also protected the mask wearer from being infected.
White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines Published: Oct. 7, 2020 By Alex Keown BioSpace The White House has reversed its position on new vaccine guidelines proposed […]
White House officials said they would block new vaccine guidance that would delay hurried approvals ahead of the Nov. 3 election.
President Donald Trump signaled the White House may attempt to override a more stringent guidance for Emergency Use Authorization of a vaccine for the novel coronavirus under consideration by the U.S.Food and Drug Administration (FDA).
